Controlled release mechanisms of spontaneously forming unilamellar vesicles  by Nieh, Mu-Ping et al.
Biochimica et Biophysica Acta 1778 (2008) 1467–1471
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamemControlled release mechanisms of spontaneously forming unilamellar vesicles
Mu-Ping Nieh a,⁎, John Katsaras a,b,c, Xiaoyang Qi d
a Canadian Neutron Beam Centre, Steacie Institute for Molecular Sciences, National Research Council Canada, Chalk River Laboratory, Chalk River, Ontario, Canada K0J 1J0
b Guelph-Waterloo Physics Institute and Biophysics Interdepartmental Group, University of Guelph, Guelph, Ontario, Canada N1G 2W1
c Department of Physics, Brock University, 500 Glenridge Avenue, St. Catharines, Ontario, Canada L2S 3A1
d Division of Human Genetics, Cincinnati Children Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio 45229, USAa r t i c l e i n f o⁎ Corresponding author. Tel.: +1 613 584 8811x6380;
E-mail address: mu-ping.nieh@nrc.gc.ca (M.-P. Nieh)
0005-2736/$ – see front matter. Crown Copyright © 20
doi:10.1016/j.bbamem.2008.02.016a b s t r a c tArticle history:
Received 18 December 2007
Received in revised form 26 February 2008
Accepted 26 February 2008
Available online 18 March 2008Spontaneously forming small unilamellar vesicles (SULVs) are easy to prepare and show great promise for use
in delivering therapeutic payloads. We report of SULVs made up of the ternary phospholipid mixture,
dimyristoyl-phosphatidylcholine (DMPC), dihexanoyl-phosphatidylcholine (DHPC) and dimyristoyl-
phosphatidylglycerol (DMPG), which have been characterized by small angle neutron scattering (SANS).
These low-polydispersity (0.14–0.19) SULVs range in size (i.e., radius) from 110 to 215 Å and are capable of
entrapping, and subsequently releasing, hydrophilic molecules (e.g., ﬂuorescent dyes and quenchers) in a
controlled fashion over two different temperature ranges. The low-temperature release mechanism involves
the SULVs transforming into discoidal micelles, with an onset temperature (To) of ~32 °C, while the high-
temperature release mechanism is more gradual, presumably the result of defects formed through the
continuous dissolution of DHPC into solution. Both of thesemechanisms differ from other, previously reported
thermosensitive liposomes.
Crown Copyright © 2008 Published by Elsevier B.V. All rights reserved.Keywords:
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Liposomes, because of their ability to entrap both hydrophilic and
amphiphilic molecules offer many possibilities for the medical and
pharmaceutical sciences. For example, in medicine they can be
utilized as carriers for therapeutic (e.g., delivery of drugs and genetic
material) [1–4] and diagnostic [e.g., incorporatingmagnetic resonance
imaging (MRI) agents] purposes [5–7], while in the agricultural and
food industries they are used to encapsulate bioactive compounds,
such as enzymes and modiﬁers used to determine environmental and
chemical changes [8]. They are also used to improve the sensitivity of
analytical measurements by encapsulating probe reagents [9].
In aqueous solutions, most of the long-chain zwitterionic phos-
pholipids (i.e., number of carbons N10) self assemble into multi-
lamellar vesicles (MLVs). However, with regards to delivery systems
and compared to SULVs, MLVs have shorter circulation half-lives
[10,11]. Therefore, one way of extending the half-life of liposomes is to
restrict their size to b100 nm in diameter [12]. Traditional methods of
manufacturing SULVs include sonication and multi-stage extrusion of
MLVs. The former usually results in SULVs that are unstable, or poly-
disperse in size, while the latter method requires extensive, iterativefax: +1 613 584 4040.
.
08 Published by Elsevier B.V. All rigprocedures, especially for the production of SULVs of a diameter
b50 nm, with the inevitable fouling of the extrusion ﬁlters.
We have previously reported on spontaneously forming SULVs
comprised of the phospholipid mixture DMPC, DHPC and DMPG [13].
These SULVs range in size between 10 and ~40 nm in radius, with
polydispersities ranging from 0.15 to 0.2 [14–16]. The SULVs were
found to be stable for extended periods (i.e., weeks) at 45 °C [15] and
were presumed to form from discoidal micelles, a morphology in
which the short-chain DHPC coats the rim of the bilayered micelle
[13]. Upon increasing the temperature, DHPC migrates into solution
and the planar parts of the membrane, resulting in neighbouring disks
coalescing, thereby reducing line tension. Eventually, these large
bilayered micelles transform into SULVs.
We have previously also reported of SULVs that assume an oblate
vesicular morphology at low-temperature and lipid concentrations
(CLp) of ≤0.1 wt.% [13]. Although these SULVs are easily prepared, it is
presently unclear whether or not their surfaces are populated with
defects formed by residue DHPC molecules, and what are their
permeability and controlled release properties.
Over the years, lipid membrane permeability has been the subject
of numerous studies. It is well known that membrane permeability
reaches a maximum around a lipid's gel-to-liquid crystalline (Lα)
transition temperature, TM (i.e., the temperature at which the lipid's
acyl chains “melt”) [17–19]. This increased permeability has pre-
viously been attributed to either, or both of the following possibilities:hts reserved.
1468 M.-P. Nieh et al. / Biochimica et Biophysica Acta 1778 (2008) 1467–1471(1) defects caused bymismatched gel and Lα phase hydrocarbon chain
domains [17,20]; (2) strong density and thermal ﬂuctuations resulting
in increased lateral membrane compressibility, which lowers the
energy barrier for molecules to pass through the membrane, or to
create defects [21,22]. This sharp increase in membrane permeability
at TM provides the possibility of controlling the release of the SULV's
contents. Other liposome release mechanisms previously investigated
include, pH-sensitive liposomes [23,24], magnetic [25] andmicrowave
induced [26], and laser-triggered release [27].
Here we examine the encapsulation and release properties of low-
polydispersity, spontaneously forming SULVs, including those in the
locked-in oblate morphology at low CLp. The results indicate that both
spherical and oblate SULVs are capable of entrapping molecules such
as, ﬂuorescent probes and quenchers. Furthermore, their release
mechanism, studied as a function of temperature, shows the presence
of two such mechanisms. At low-T there is a sudden release of the
SULV's contents, the result of a morphological change (SULVs
transforming into discoidal micelles), while at high-T there is a
gradual release of the SULV's contents, most likely the result of defects
caused by the migration of DHPC into solution.
2. Experimental method
2.1. Sample preparation
DMPC, DMPG and DHPC were purchased from Avanti Polar Lipid Inc. and used
without further puriﬁcation. Low-polydispersity SULVs were prepared following the
procedure described in [13], exception being that the D2O solvent contained 12.5 mM of
the ﬂuorescent probe, 8-aminonaphthalene-1,3,8-trissulfonic disodium salt (ANTS) and
45 mM of the ﬂuorescent quencher, p-xylene-bis-pyridinium bromide (DPX). Both
agents were purchased from Invitrogen Canada Inc. For Small Angle Neutron Scattering
(SANS), two samples of CLp 1 wt.% and 0.1 wt.% were prepared, while 1 wt.% and 0.2 wt.%
samples were used for ﬂuorescence experiments. All samples were prepared at 4 °C.
2.2. Small angle neutron scattering (SANS)
SANS is commonly used to determine the global morphologies of aggregates in
solutions by iteratively ﬁtting a model to the SANS data. Model parameters include ULV
size, shape and polydispersity. SANS experiments were conducted using the NG3 SANS
instrument located at the NIST Centre for Neutron Research (NCNR, Gaithersburg,
Maryland). A neutronwavelength, k, of 6 Å (FWHM=15%) and three sample-to-detector
distances (SDD) (i.e., 1, 5 and 13 m) were used to cover a q range from 0.003 to 0.36 Å−1,
where the scattering vector, q, is deﬁned as 4π d sin(θ /2) /k, and where θ is the
scattering angle. SANS data were analyzed as follows: Scattered curves were collected
by a 2-D detector and corrected for detector sensitivity, transmission, empty cell and
background. The corrected data were then circularly averaged around the beam centre
to obtain the 1-D scattering proﬁle as a function of q. The data were then normalized,
using the incident neutron ﬂux, and put on an absolute scale. Incoherent scattering (a
constant value) was estimated from the intensity in the high q region and subtracted
from the various data sets.
In order to determine the morphologies and dimensions of the aggregates, reduced
SANS data were ﬁtted with the appropriate models, which were “smeared” using the
instrumental resolution. In the case of low-temperature (10 °C) samples, a core–shell
disk model describing discoidal micelles with a hydrophobic (lipid hydrocarbon chains)
core and a hydrophilic (head groups of lipids) shell is used to ﬁt the SANS data. There are
ﬁve ﬁtting parameters: a) scattering length densities (SLD) of core (ρcore) and shell
(ρshell), b) core radius (Rcore), c) shell thickness (tshell) and d) the thickness of the
discoidal core (tcore). As for high-temperature (45 °C) samples, a spherical single shell
model is used, where a uniform SLD for the lipid shell (ρlip) is assumed and which
includes four ﬁtting parameters: a) ρlip, b) the inner radius of the spherical shell (Rin),Fig. 1. Photographs of an initially “loaded” sample and its subsequent fractions. Increasing ﬂu
SULVs, ANTS and DPX (1 ml) was injected into a PD-10 column and the sample was eluted usi
in fraction #4. ANTS and DPX free in solution were eluted in fractions #6–8.c) shell thickness (tlip) and d) the polydispersity of Rin. The SLD of D2O (6.38×10−6 Å−2)
remains constant for both models and the best ﬁt values of ρcore, ρshell and ρlipid are
constrained to the vicinity of the published values (e.g., −4.3×10−7 Å−2, 3.2×10−6 Å−2
and 3.2×10−7 Å−2, respectively) [15]. The best ﬁt results of parameters with known
values (i.e., bilayer thickness, head group size and hydrocarbon chain lengths) must be
consistent, within acceptable limits, with published data. Detailed descriptions of the
models can be found in [13,15].
2.3. Characterization of SULV encapsulation
The encapsulation of ANTS/DPX in SULVs was characterized using ﬂuorescence
measurements at 10 and 45 °C. ANTS and DPX in solution (i.e., not within the SULVs)
were removed using a PD-10 desalting column (Amersham Pharmacia Biotech,
Piscataway, NJ) at a T of 10 or 45 °C. Differing size aggregates were eluted and collected
as a function of time. The PD-10 column, containing a Sephadex™ G-25 medium that
separates high molecular weight (MWN5000) from low MW (b1000) materials, was
equilibrated with 25 ml of PBS. After running PBS through the column, a total sample
volume of 1 ml was introduced to the column, and the sample was eluted using PBS.
SULVs containing ANTS/DPXwere collected from the 4th fraction, the one exhibiting the
most intense ﬂuorescence (as shown in Fig. 1). The higher ﬂuorescent intensity of SULV
(4th fraction), compared to free ANTS/DPX (5th–8th fractions), is most likely due either
to non stochiometric amounts of the ﬂuorecent molecule (ANTS) and quencher (DPX)
within the SULVs, or the fact that ANTS, because of its very small size compared to
SULVs, is distributed over the four fractions (5th–8th).
The ﬂuorescence intensity of eluted SULV samples was then measured using an
SLM-Aminco Bowman Series 2 luminescence spectrometer (SLM Instruments Inc.,
Urbana, IL). In the case of SULVs containing ANTS and DPX, ﬂuorescence intensity was
weak as ANTS is quenched by DPX. However, when ANTS and DPX leak into solution,
either via the addition of Triton X-100 or when triggered by temperature, ﬂuorescence
intensity dramatically increases, a phenomenon known as “dequenching”. Fluorescence
measurements were performed in 1-ml quartz cells under constant magnetic stirring.
The excitation and emission wavelengths were at 360 nm and 520 nm, respectively,
each with a 4 nm bandwidth. All samples were incubated at 45 °C for 1 h (to form
SULVs) prior to experimentation. For constant-T studies (i.e., 10 and 45 °C) ﬂuorescence
was continuously measured while Triton X-100 was added to disrupt the SULVs,
dequenching the ANTS. For temperature scan experiments, sample temperature was
controlled using an SLM thermostated cuvette holder in conjunction with a Lauda
(model MGW MS) water bath (−20 to 120 °C) and an MA6 circulating bath (Lauda
Division, Brinkmann Instruments). As a result, we were able to follow the dynamic
response of the SULVs as a function of T.
3. Results and discussion
3.1. Characterization of SULVs
SULV SANS data at 10 and 45 °C are shown in Fig. 2 (a) and (b),
respectively. The solid curves represent the best ﬁts to the data using
bilayered discoidal and vesicular models to describe the data at 10 and
45 °C, respectively. Although the models nicely describe the 1 wt.%
data, this is not the case for the 0.1 wt.% sample at qb0.005 Å−1 — a
discrepancy most likely due to the presence of large aggregates co-
existingwith SULVs. Importantly, the dimensions and polydispersity of
the SULVs and discoidal micelles (Table 1) in the present study, show
trends similar to those reported previously [28–30], conﬁrming that
the addition of ANTS and DPX does not perturb the system's inherent
structures.
SULV radii are in the range of 100–250 Å, suitable for most drug
deliveryapplications.Moreover, their polydispersities are less than 0.2,
comparable to those of SULVs produced via the multi-stage extrusion
method. Low-polydispersity SULVs at elevated T are obtained fromorescence intensity is represented by the increasing number of plus signs. A mixture of
ng PBS (1.6 ml/fraction). The majority of the SULVs containing ANTS and DPXwere found
Table 1
The structural parameters of the best ﬁts to the SANS data
Low-T (10 °C) core–shell disk
model
High-T (45 °C) spherical vesicular
model
Core
radius
(Rcore)
Shell
thickness
(tshell)
Core
thickness
(tcore)
Inner
radius
(Rin)
Membrane
thickness
(tlip)
Polydispersity
(p)
1 wt.% 125±5 17±2 27±6 180±1 34.2±0.5 0.14±0.01
0.1 wt.% 142±8 19±4 30±9 82±1 35±1 0.19±0.01
⁎Dimensions are in Å.
⁎⁎The discoidal micelles and vesicles are ﬁtted using core–shell disk and spherical shell
models, respectively [13,15].
Fig. 3. Fluorescence measurements of (a) 1.0 wt.% and (b) 0.2 wt.% SULVs containing
ANTS and DPX. Solid, dashed and dotted lines represent SULVs at 45 °C and 10 °C, and a
reference phosphate buffer solution (PBS) at room temperature (no SULVs), respectively.
The arrows indicate the addition of Triton X-100 that resulted in disrupting the SULVs,
thus dequenching the ﬂuorescence probes. There is no effect in ﬂuorescence intensity
with regards to the PBS sample, or when the lipid mixture is in the discoidal micelle
morphology.
Fig. 2. SANS data of 1.0 wt.% (circles) and 0.1 wt.% (triangles) samples at (a) 10 °C and
(b) 45 °C. The solid curves represent the best ﬁts to the data using the core–shell disk
(10 °C) and spherical shell (45 °C) models (inset to the ﬁgures).
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DMPG) gel lipids and the short-chain (i.e., DHPC) liquid crystalline
lipid, are immiscible. In this case, DHPC sequesters at the disk's rim
minimizing the energy caused by the high curvature. As the long-chain
lipids undergo a phase transition (fromgel to Lα), with increasing T, the
rim of the discoidalmicelles becomes unstable due to the loss of DHPC.
This loss may take place as follows:
1. The short-chain lipids begin to mix with the long-chain lipids, as
they are now both in the Lα phase.
2. With increasing T, DHPC becomes more water-soluble than DMPC,
thus altering the micelle's long- to short-chain lipid ratio.
Consequently, in order for the discoidal micelles to reduce their
rim to surface area ratio, they coalesce with neighbouring micelles,
eventually leading to the formation of SULVs. Previous studies
demonstrated that different preparation paths could result in varying
SULV size and polydispersities [13]. Although one can debate whether
or not these SULVs are thermodynamically stable, we have consis-
tently found them to be stable over the period of weeks [15], and in
some cases, months [31].3.2. Encapsulation and release of the SULV
3.2.1. Concentration and temperature effects on encapsulation
An important property of SULV's as carriers is their capacity to
encapsulate material. Fig. 3(a) illustrates, as a function of time, the
ﬂuorescence properties of 1 wt.% SULV after going through the PD-10
column, at 10 and 45 °C [the ﬂuorescence response of a phosphate
buffer solution (PBS) is also included in the ﬁgure as a control sample
for the addition of Triton X-100, the same for Fig. 3(b) and Fig. 4]. At
45 °C, ﬂuorescence intensity remains stable until the addition of Triton
X-100, which disrupts the vesicular structure and dequenches the
Fig. 4. Temperature dependence of ﬂuorescence dequenching curves for SULVs and PBS.
SULVs formed at 45 °C, were either heated or cooled. As the temperature is varied at a
continuous rate, the x-axis is given as units of time. From this, it is obvious that the
SULVs leak as T is increased beyond 45 °C, while on decreasing T, they are stable until an
abrupt release at 32 °C. The dotted line represents the controlled sample, PBS.
1470 M.-P. Nieh et al. / Biochimica et Biophysica Acta 1778 (2008) 1467–1471ﬂuorescent probes through the release of ANTS and its quencher, DPX.
This indicates that SULVs contain both the probe and quencher
after being eluded from the separation column. However, at 10 °C, the
1 wt.% sample shows no indication of encapsulation, as no signiﬁcant
increase in ﬂuorescence intensity is observed after the addition of
Triton X-100. This result is consistent with the discoidal micelle
morphology determined by SANS.
In the case of the 0.2 wt.% sample shown in Fig. 3(b), 45 °C SULVs
behave similarly to those making up the 1 wt.% sample, however, they
differ at 10 °C where 0.2 wt.% aggregates are found encapsulating
ANTS and DPX. Previously, we reported that low concentration SULVs
(CLp≤0.1 wt.%) ﬁnd themselves in the locked-in morphology (i.e., not
reverting to discoidal micelles) even at low-Ts, except that instead of
being spherical they become oblate [13]. Our current observation is
certainly in agreement with what we previously reported.
In summary, the ﬂuorescence results can be summarized as follows:
1. They are consistent with all of the structures determined from
SANS experimentation namely, the presence of discoidal micelles
at low-T, SULVs at high-T and oblate vesicles at low-T and low CLp.
2. The SULVs (or oblate vesicles) are not leaky. This implies that
membrane defects resulting from DHPC at low-T, disappear when
the SULVs are formed. It seems that the SULVs are impermeable to
anything larger than ANTS or DPX.
3.2.2. Release mechanism as a function of temperature
It is well known that the permeability of liposomes approaches a
maximum near a phospholipid's TM [17–20], enabling the controlled
release of temperature-regulated liposomes. Previously, many efforts
were made to produce thermally modulated vesicles by altering lipid
compositions [32], and the addition of cholesterol [17,18] and alcohols
[33,34]. To the best of our knowledge, the detailed release mechanism
and associated morphologies of spontaneously forming SULVs has not
been previously studied. Fig. 4 illustrates the release of ANTS and DPX
encapsulated in 1 wt.% SULVs both on increasing and decreasing
temperature. The aforementioned release mechanisms are observed.
With increasing T, ﬂuorescence intensity slowly increases, indicative
of the SULVs slowly releasing their contents, while with decreasing T
ﬂuorescence intensity remains constant until a sudden increase at
32 °C when the SULVs undergo a morphological change (SULVs to
discoidal micelles), abruptly releasing their contents. The observation
of SULVs gradually releasing their contents is not well understood, andhas not been previously observed in vesicles of pure lipids. A possible
explanation may be that, with increasing T DHPC becomes increas-
ingly more water-soluble, causing the SULVs to become more leaky
through the formation of defects. Regardless of the mechanism, the
results presented here are encouraging in that the SULVs remain
stable and impermeable with decreasing T, until 32 °C. Moreover, both
release mechanisms differ from those previously reported in lipid
systems, which usually take place near a phospholipid's TM [17–19].
4. Conclusion
We have reported on the structures and temperature dependent
release mechanisms of a phospholipid mixture which spontaneously
forms low-polydispersity SULVs. The system yields SULVs at high-T and
discoidal micelles at low-T. At low CLp, the SULV morphology can be
locked-in and remain unaltered throughout the temperature range
studied. Between 32 and 45 °C, the liposomes exhibit good encapsula-
tion properties. Compared to SULVs produced by traditional methods,
the present system is unique in that it exhibits two thermosensitive
release mechanisms (i.e., fast and slow release), illustrating its inherent
ﬂexibility. Importantly for industrial production, these SULVs are easy to
prepare in large quantities. Presently, we are incorporating other
components (e.g., cholesterol, PEGylated lipid and antibodies) into the
system in order to produce more impermeable, targeted and stealth
SULVs.
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